CHUGAI PHARMA FRANCE Competitors and Similar CompaniesClear all

CHUGAI PHARMA FRANCE's competitors and similar companies include Agios Pharmaceuticals, Turning Point Therapeutics, Helsinn Group and Pharmstandard.
CHUGAI PHARMA FRANCE
CHUGAI PHARMA FRANCE
CHUGAI PHARMA FRANCE is a company that specializes in pharmaceutical products.
Agios Pharmaceuticals
Agios Pharmaceuticals
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
Turning Point Therapeutics
Turning Point Therapeutics
Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases.
Helsinn Group
Helsinn Group
Helsinn Group is a pharmaceutical company that focuses on therapeutic and supportive care products for cancer.
Pharmstandard
Pharmstandard
Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.
Founding Date
Founding Date
1998
Founding Date
2008
Founding Date
2013
Founding Date
1976
Founding Date
2003
Type
Type
Subsidiary
Type
Public
Type
Subsidiary
Type
Private
Type
Subsidiary
Tags
Locations
Locations
Paris, FR HQ
Locations
Cambridge, US HQ
Locations
San Diego, US HQ
Locations
Pazzallo, CH HQ
Shanghai, CN
Monaco, MC
Biasca, CH
Woodbridge Township, US
Locations
Dolgoprudny, RU HQ
Kursk, RU
Moscow, RU
Tomsk, RU
Ufa, RU
Employees
Employees
7517% decrease
Employees
53611% increase
Employees
25024% increase
Employees
400
Employees
1,56135% increase

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$26.8m (FY, 2023)
Revenue (est.)
$30.8m (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
₽142.9b (FY, 2023)
Cost of goods
Cost of goods
N/A
Cost of goods
$2.9m (FY, 2023)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
₽109.3b (FY, 2023)
Gross profit
Gross profit
N/A
Gross profit
$23.9m (FY, 2023)
Gross profit
N/A
Gross profit
N/A
Gross profit
₽33.6b (FY, 2023)
Net income
Net income
N/A
Net income
($352.1m) (FY, 2023)
Net income
($236.6m) (FY, 2021)
Net income
N/A
Net income
₽23.3b (FY, 2023)
For sources of this data, please see the company profile

View Company Profiles

Agios Pharmaceuticals
HQ
Cambridge, US
Employees
536↑ 11% increase

Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.

View company
Turning Point Therapeutics
HQ
San Diego, US

Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases.

View company
Helsinn Group
HQ
Pazzallo, CH
Employees
400

Helsinn Group is a pharmaceutical company that focuses on therapeutic and supportive care products for cancer.

View company
Pharmstandard
HQ
Dolgoprudny, RU

Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.

View company